Semaglutide vs Tirzepatide
GLP-1 mono-agonist vs dual GIP/GLP-1 agonist
Semaglutide vs Retatrutide
Single-receptor vs triple-receptor agonism
Tirzepatide vs Retatrutide
Dual agonist vs triple agonist
Semaglutide vs Liraglutide
Weekly vs daily GLP-1 receptor agonists
Tirzepatide vs Cagrilintide
Incretin pathway vs amylin pathway
Retatrutide vs Cagrilintide
Triple incretin agonist vs long-acting amylin analog
Orforglipron vs Semaglutide
Oral non-peptide vs injectable peptide GLP-1 RA
BPC-157 vs TB-500 (Thymosin Beta-4 fragment)
Two of the most studied healing-research peptides
BPC-157 vs GHK-Cu
Systemic healing peptide vs copper-binding tripeptide
TB-500 (Thymosin Beta-4 fragment) vs GHK-Cu
Thymosin beta-4 fragment vs copper peptide
BPC-157 vs Glutathione
Repair-signaling peptide vs antioxidant tripeptide
CJC-1295 vs Sermorelin
Long-acting vs short-acting GHRH analog
CJC-1295 vs Ipamorelin
GHRH analog vs ghrelin-receptor agonist
MK-677 (Ibutamoren) vs CJC-1295
Oral ghrelin mimetic vs injectable GHRH analog
GHRP-2 vs GHRP-6
Two ghrelin mimetics with distinct appetite profiles
Tesamorelin vs CJC-1295
FDA-approved GHRH(1-44) vs research GHRH(1-29) with DAC
Hexarelin vs GHRP-6
Cardioprotective ghrelin mimetic vs appetite-driving counterpart
NAD+ vs NMN (Nicotinamide Mononucleotide)
Direct coenzyme administration vs precursor strategy
NMN (Nicotinamide Mononucleotide) vs NR (Nicotinamide Riboside)
Two oral NAD+ precursors with different metabolic routing
Epitalon vs NAD+
Pineal tetrapeptide vs mitochondrial coenzyme
Selank vs Semax
Anxiolytic-leaning vs cognition-leaning Russian nootropic peptides
Semax vs Cerebrolysin
Defined heptapeptide vs porcine-brain neurotrophic mixture
PT-141 (Bremelanotide) vs Melanotan II
MC3/MC4-preferring agonist vs non-selective melanocortin agonist
Semaglutide vs Retatrutide
How single-pathway and triple-pathway incretin therapies differ
Semaglutide vs Liraglutide
How GLP-class peptides reframe pharmacologic weight management